ICONA Pn Eyes Polynucleotide

ICONA® Pn EYES: Polynucleotide -based regenerator for the periorbital area

ICONA® Pn Eyes is a delicate injectable formulated for thin, fragile under-eye skin. With 15mg/2ml polynucleotides, amino acids, and carnosine, it supports tissue repair, dermal thickening, and visible brightening — without volume, puffiness, or structural change.

Multi-zone Polynucleotides Formulas
Each ICONA® Pn+ product is precisely formulated for its treatment zone — face, body, eyes, or scalp. With targeted concentrations of polynucleotides and co-factors, the range offers medical professionals a regenerative solution tailored to specific anatomical needs.

R³ Regenerative Technology
Powered by R³ Technology™, ICONA® Pn+ supports controlled tissue repair across all indications. This structured 3-phase system — Repair, Restore, Reinforce — helps regenerate dermal structure, improve elasticity, and optimise the extracellular environment.

Natural, Non-Volumising Outcomes
Designed for subtle yet clinically meaningful results, ICONA® Pn+ improves skin texture, hydration, and density without adding volume. Patients experience visible quality improvements with minimal downtime — ideal for high-demand, natural-look rejuvenation.

Polynucleotides (15mg/2ml)
Low-dose PN formula ideal for fragile under-eye tissue. Promotes dermal thickening, collagen renewal, and skin tone improvement.

Amino Acid Complex
Supports cellular repair and microcirculation in the periorbital region.

Carnosine
A potent antioxidant and anti-glycation peptide that protects against free radical and environmental stressors.

R³ Technology™
Gentle, layered repair designed for the delicate eye area.

ICONA® Pn+ injectables are delivered via precise micro-injections into targeted dermal planes based on the treatment zone — including facial, body, periocular, and scalp applications. This strategic protocol ensures optimal absorption of active ingredients while minimising downtime and inflammation.

Using micro-bolus or mesotherapy techniques depending on indication, the polynucleotide-based solution is introduced into the extracellular matrix. Once there, it stimulates fibroblast proliferation, enhances collagen and elastin synthesis, supports angiogenesis, and improves tissue hydration — all without altering volume or facial structure.